剖宫产后脂质体布比卡因的布比卡因药代动力学及母乳排泄
前瞻性队列研究纳入30例足月剖宫产健康孕妇,在腹横肌平面阻滞中使用52 mg盐酸布比卡因0.25%(20 mL)与266 mg脂质体布比卡因1.3%(20 mL)。母乳布比卡因浓度6小时达峰(均值58 ng/mL),96小时降至均值5.2 ng/mL;各时间间期相对新生儿剂量均低于1%,未发生新生儿严重不良反应。
要点
- 母乳布比卡因浓度6小时达峰(均值58 ng/mL),96小时降至均值5.2 ng/mL。
- 母体血浆浓度双峰:6小时均值155.9 ng/mL,48小时均值225.8 ng/mL。
- 各时间间期相对新生儿剂量均低于1%,未发生新生儿严重不良反应。
核心结论
- 剖宫产后腹横肌平面阻滞局部浸润脂质体布比卡因与盐酸布比卡因混合物后,布比卡因可排泄入母乳。
- 相对新生儿剂量低于1%(低于10%被认为不太可能具有临床关注),提示对健康足月新生儿哺乳风险极小。
研究设计与样本
- 前瞻性队列研究,纳入30例足月剖宫产健康孕妇。
- 腹横肌平面阻滞使用52 mg盐酸布比卡因0.25%(20 mL)与266 mg脂质体布比卡因1.3%(20 mL)。
- 阻滞后2、6、12、24、48、72、96小时交错采集血与乳汁,每例3至4份样本,液相色谱-串联质谱法定量布比卡因。
- 通过计算乳汁/血浆曲线下面积(AUC)比值、新生儿剂量及各采样时间相对新生儿剂量来模拟新生儿药物暴露。
主要发现
- 母乳浓度6小时达峰(均值58 ng/mL),随后持续稳定下降至96小时低水平(均值5.2 ng/mL)。
- 母体血浆浓度呈双峰,第一峰在6小时(均值155.9 ng/mL),第二峰在48小时(均值225.8 ng/mL),随后稳定下降。
- 乳汁/血浆AUC0-t比值介于AUC0-2的0.45(80% CI 0.38-0.52)与AUC0-96的0.15(80% CI 0.14-0.17)之间。
- 新生儿剂量介于0-2小时均值355.9 ng/kg与0-96小时均值15,155.4 ng/kg之间。
- 各时间间期相对新生儿剂量均低于1%,未发生新生儿严重不良反应。
关键数值与推荐
- 相对新生儿剂量低于1%被视为不太可能具有临床关注(原文以低于10%为界)。
临床怎么用
- 作者认为,剖宫产后腹横肌平面阻滞使用该局部麻醉药组合后,健康足月新生儿哺乳风险极小。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate bupivacaine concentrations in maternal plasma and transfer into breast milk in women undergoing liposomal bupivacaine infiltration in the transversus abdominis plane after cesarean birth. METHODS: Prospective cohort study of healthy pregnant women who underwent cesarean birth at term followed by a transversus abdominis plane block using 52 mg bupivacaine hydrochloride 0.25% (20 mL) and 266 mg liposomal bupivacaine 1.3% (20 mL). Simultaneous blood and milk samples were collected in a staggered fashion, three to four samples per patient at the following timepoints after block administration: 2, 6, 12, 24, 48, 72, and 96 hours. Quantification of bupivacaine was performed by liquid chromatography-tandem mass spectrometry. Neonatal drug exposure was modeled by calculating milk/plasma area under the curve (AUC) ratios, neonatal dosage, and relative neonatal dosage of bupivacaine at each sampling time. RESULTS: Thirty patients were enrolled. Concentrations in breast milk peaked at 6 hours (mean 58 ng/mL), followed by constant and steady decline to low levels at 96 hours (mean 5.2 ng/mL). Maternal plasma concentrations had two peaks, first at 6 hours (mean 155.9 ng/mL) and then at 48 hours (mean 225.8 ng/mL), followed by steady decline. Milk/plasma AUC0-t ratios ranged between AUC0-2 of 0.45 (80% CI 0.38-0.52) and AUC0-96 of 0.15 (80% CI 0.14-0.17). Neonatal dosage ranged between a mean of 355.9 ng/kg at 0-2 hours and a mean of 15,155.4 ng/kg at 0-96 hours. Relative neonatal dosage was less than 1% at all time intervals. No serious adverse reactions occurred in any neonate. CONCLUSION: Bupivacaine is excreted in breast milk after local infiltration of liposomal bupivacaine and bupivacaine hydrochloride mixture into transversus abdominis plane blocks after cesarean birth. Relative neonatal dosages of less than 1% (less than 10% is considered to be unlikely to be of clinical concern) suggest minimal risks for breastfeeding healthy, term neonates after the administration of this combination of local anesthetics to mothers. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT03526419.
引用
- Mustafa HJ, Wong HL, Al-Kofahi M, et al. Bupivacaine Pharmacokinetics and Breast Milk Excretion of Liposomal Bupivacaine Administered After Cesarean Birth. Obstet Gynecol. 2020. PMID: 32541292. doi:10.1097/AOG.0000000000003886
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。